Mirko Buchholz

Publication Activity (10 Years)

Years Active: 2020-2023
Publications (10 Years): 6

Top Topics

Photodynamic Therapy

Molecular Docking

Structure Activity Relationship

Top Venues

Journal of enzyme inhibition and medicinal chemistry

Pharmaceuticals (Basel, Switzerland)

This page only lists publications with an associated author ORCID identifier.

Publications

Kathrin Tan, Christian Jäger, Stefanie Geissler, Dagmar Schlenzig, Mirko Buchholz, Daniel Ramsbeck
Synthesis and structure-activity relationships of pyrazole-based inhibitors of meprin α and β. Journal of enzyme inhibition and medicinal chemistry 38 (1) (2023)
Kathrin Tan, Christian Jäger, Stefanie Geissler, Dagmar Schlenzig, Mirko Buchholz, Daniel Ramsbeck
Synthesis and structure-activity relationships of pyrazole-based inhibitors of meprin α and β. Journal of enzyme inhibition and medicinal chemistry 38 (1) (2023)
Kathrin Tan, Christian Jäger, Stefanie Geissler, Dagmar Schlenzig, Mirko Buchholz, Daniel Ramsbeck
Synthesis and structure-activity relationships of pyrazole-based inhibitors of meprin α and β. Journal of enzyme inhibition and medicinal chemistry 38 (1) (2023)
Daniel Ramsbeck, Nadine Taudte, Nadine Jänckel, Stefanie Strich, Jens-Ulrich Rahfeld, Mirko Buchholz
Tetrahydroimidazo[4,5- c ]pyridine-Based Inhibitors of Porphyromonas gingivalis Glutaminyl Cyclase. Pharmaceuticals (Basel, Switzerland) 14 (12) (2021)
Kathrin Tan, Christian Jäger, Hagen Körschgen, Stefanie Geissler, Dagmar Schlenzig, Mirko Buchholz, Walter Stöcker, Daniel Ramsbeck
Heteroaromatic Inhibitors of the Astacin Proteinases Meprin α, Meprin β and Ovastacin Discovered by a Scaffold-Hopping Approach. ChemMedChem 16 (6) (2020)
Hagen Körschgen, Christian Jäger, Kathrin Tan, Mirko Buchholz, Walter Stöcker, Daniel Ramsbeck
A Primary Evaluation of Potential Small-Molecule Inhibitors of the Astacin Metalloproteinase Ovastacin, a Novel Drug Target in Female Infertility Treatment. ChemMedChem 15 (16) (2020)